CUMBERLAND PHARMACEUTICALS (CPIX) Stock Balance Sheet
NASDAQ:CPIX • US2307701092
Current stock price
3.01 USD
-0.05 (-1.63%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 11.44M | 17.96M | 18.32M | 19.76M | 27.04M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 16.94M | 11.70M | 9.76M | 13.16M | 6.88M | |||
| Inventories | 6.23M | 4.00M | 4.61M | 9.86M | 8.43M | |||
| Other Current Assets | 2.45M | 2.79M | 3.03M | 3.08M | 3.34M | |||
| Total Current Assets | 37.06M | 36.45M | 35.71M | 45.87M | 45.69M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.61M | 6.45M | 7.04M | 5.50M | 1.47M | |||
| Investments And Advances | 3.99M | N/A | N/A | N/A | N/A | |||
| Goodwill | 914.00K | 914.00K | 914.00K | 914.00K | 882.00K | |||
| Intangibles | 14.03M | 17.97M | 22.61M | 30.59M | 23.95M | |||
| Other Non-Current Assets | 12.23M | 13.79M | 15.50M | 10.05M | 12.47M | |||
| Total Non-Current Assets | 39.76M | 39.13M | 46.06M | 47.05M | 38.77M | |||
| TOTAL ASSETS | 76.82M | 75.58M | 81.78M | 92.93M | 84.46M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 5.10M | N/A | N/A | N/A | |||
| Accrued Expenses | 467.80K | 1.83M | 1.55M | 2.22M | 2.33M | |||
| Accounts Payable | 18.57M | 13.91M | 14.04M | 10.82M | 9.64M | |||
| Other Current Liabilities | 17.71M | 10.78M | 12.40M | 15.54M | 7.31M | |||
| Total Current Liabilities | 36.74M | 31.62M | 27.98M | 28.58M | 19.28M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 5.24M | 10.18M | 12.78M | 16.20M | 15.00M | |||
| Other Non-Current Liabilities | 10.29M | 11.24M | 11.75M | 12.17M | 7.58M | |||
| Total Non-Current Liabilities | 15.20M | 21.11M | 24.19M | 28.08M | 22.37M | |||
| TOTAL LIABILITIES | 51.94M | 52.73M | 52.17M | 56.66M | 41.65M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -26.80M | -23.97M | -17.49M | -11.21M | -5.64M | |||
| Minority Interest | -336.10K | -307.50K | -343.60K | -292.10K | -212.30K | |||
| Common Shares | 51.68M | 46.82M | 47.09M | 47.48M | 48.45M | |||
| Shares Outstanding | 14.96M | 13.95M | 14.12M | 14.37M | 14.74M | |||
| Tangible Book Value per Share | 0.66 | 0.28 | 0.43 | 0.33 | 1.22 | |||
| Total Shareholders' Equity | 24.88M | 22.85M | 29.60M | 36.27M | 42.81M | |||
| TOTAL LIABILITIES AND EQUITY | 76.82M | 75.58M | 81.78M | 92.93M | 84.46M | |||
| Statistics | ||||||||
| Debt/Equity | 0.21 | 0.45 | 0.43 | 0.45 | 0.35 | |||
| Current Ratio | 1.01 | 1.15 | 1.28 | 1.60 | 2.37 | |||
| Return On Assets (ROA) | -3.69% | -8.57% | -7.68% | -5.99% | -4.15% | |||
| Return On Equity (ROE) | -11.40% | -28.35% | -21.21% | -15.36% | -8.19% | |||
All data in USD , ROIC based on taxRate of 0.21